<code id='276E7E040F'></code><style id='276E7E040F'></style>
    • <acronym id='276E7E040F'></acronym>
      <center id='276E7E040F'><center id='276E7E040F'><tfoot id='276E7E040F'></tfoot></center><abbr id='276E7E040F'><dir id='276E7E040F'><tfoot id='276E7E040F'></tfoot><noframes id='276E7E040F'>

    • <optgroup id='276E7E040F'><strike id='276E7E040F'><sup id='276E7E040F'></sup></strike><code id='276E7E040F'></code></optgroup>
        1. <b id='276E7E040F'><label id='276E7E040F'><select id='276E7E040F'><dt id='276E7E040F'><span id='276E7E040F'></span></dt></select></label></b><u id='276E7E040F'></u>
          <i id='276E7E040F'><strike id='276E7E040F'><tt id='276E7E040F'><pre id='276E7E040F'></pre></tt></strike></i>

          Home / explore / leisure time

          leisure time


          leisure time

          author:entertainment    Page View:624
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In